Indian Pharma Industry

Brands with similar or identical names will be prohibited from being marketed. Drug manufacturers will soon be required to upload detailed formulation information alongside their brand names to a government portal.

API industry facing 40% shortage of leadership talent, has no women in top positions: Report

As manufacturing networks become more complex, leading companies have specifically beefed up the hiring of Chief Operating Officer (COO) candidates, according to a report by executive search firm WalkWater Talent Advisors.

Indian pharma firms hiring former USFDA officers to tide over compliance issues

Lupin has hired a former USFDA officer to tide over compliance issues and it is not the only company to do so. The street believes this will help the company but past such hirings have not always been successful.

Interview | Russia-Ukraine war piles stress on Indian pharma industry, says Sudarshan Jain of IPA

Indian drug makers should focus on raising the quality of their products to capture 5-6 percent of global pharma sales by 2030, says the secretary general of the Indian Pharmaceutical Alliance  

Decoding PLI: A booster dose for  API manufacturing, but not strong enough

The domestic pharmaceutical industry needs much more than a PLI scheme to reduce its heavy dependence on China for raw materials

Indian companies stay put in Russia but pharma exports could be hit

Dr Reddy's, India's fourth-biggest pharmaceutical company by market value, sells pain killers and other medicines in Russia. It is the main distributor in India for Russia's Sputnik COVID-19 vaccines.

Govt stops short of imposing export ban on essential drugs, asks industry to self-regulate supply

While the industry has assured that it has sufficient inventory for 2-3 months in view of the holiday period in China, and expectations of supplies from China resuming by end of February, the government had a rethink.

Centre plans to reduce Indian pharma cos' dependence on Chinese imports

The drug exports to China are minor in terms of value. But, India imports raw materials upto $6 billion, according to Pharmaceuticals Export Promotion Council (Pharmexcil).

Pharma industry eyes generic drug exports to Japanese market

Appaji said the country exports its one-third pharma products to US alone. "But we are looking at more opportunities in Japan and Latin American markets," he said.

ICRA expects drug formulation industry to grow at 10-12%

ICRA has come out with its release on Indian pharma industry. According to research firm, drug formulation industry is expected to grow at 10-12% in 2013-14. Growth opportunities intact but managing industry challenges remains key for Indian pharmaceutical industry, says ICRA.

Drug prices set to get cheaper, pharma cos worry

CNBC-TV18's Archana Shukla reports that the recently notified Drug Price Control Order (DPCO) will bring down the prices of 348 essential drugs by as much 35-40 percent and may see a rejig in pharma companies' rankings.

SC ruling on cancer drug big relief for consumers

The Supreme Courts‘s rejection of Novartis‘ patent plea for cancer drug Glivec comes as a big relief for consumers and is also a positive development for domestic generic pharmaceutical industry, experts said.